期刊文献+

托法替尼合成路线图解 被引量:3

Graphical synthetic routes of tofacitinib
原文传递
导出
摘要 目的:通过分析现有的托法替尼合成方法找到适合工业化生产的路线。方法:对托法替尼的合成路线进行总结。结果:路线1b条件温和,总收率较高,更加适于工业化生产。结论:在得到关键片段后,经后续反应得到托法替尼。 Objective: To review the existing synthetic routes of tofacitinib, and find the suitable route for industrialization. Methods: We summarized the various synthetic process of tofacitinib. Results:The route lb, with the moderate reaction conditions and a high total yield, shows more favorable in manufacturing scale. Conclusion: After getting the key fragments and by the subsequent reaction we can get tofacitinib.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第11期1298-1303,共6页 Chinese Journal of New Drugs
关键词 托法替尼 逆合成分析 手性合成 合成路线图解 tofacitinib retrosynthetic analysis chiral synthesis graphical synthetic routes
  • 相关文献

参考文献13

  • 1FDA. FDA approves Xeljanz for rheumatoid arthritis[EB/OL] . 2012[2015 -03 -12]. http://www.fda.gov/newsevents/news?room/pressannouncements/ucm327152. html.
  • 2王士伟,谭初兵,徐为人.新型类风湿关节炎治疗药物托法替尼[J].中国新药杂志,2013,22(14):1607-1609. 被引量:10
  • 3赵方露,陈国华,姚世伦,张贞霞.枸橼酸托法替尼的合成[J].中国医药工业杂志,2014,45(3):201-204. 被引量:12
  • 4BHIRUD SB, MISHRA S, NARAYANAN SB, et at. Process for the preparation of tofacitinib and intermediates thereof: WO, 2014102826 Al[PJ. 2013 -12 - 27.
  • 5王铁英,胡春.托法替尼柠檬酸盐(Tofacitinib)[J].中国药物化学杂志,2013,23(2):166-167. 被引量:3
  • 6LARSEN SD, GRIECO PA. Aza Diels-Alder reactions in aque?ous solution: cyclocondensation of dienes with simple iminium salts generated under Mannich conditions[J].J Am Chem Soc, 1985, 107(6): 1768 -1769.
  • 7CAl WL, COLONYJL, FROST H, et at. Investigation of practi- cal routes for the kilogram-scale production of cis-3-methylamino- 4-methylpiperidines[J]. Org Process Res Dev, 2005, 9 ( 1 ) : 51 - 56.
  • 8WILCOX GE, KOECHER C, VRIES T, et al. Optical resolution of ( I-benzyI4-methylpiperidi-3 -yl ) -rnethylamine and thereof for the preparation of pyrrolo-2, 3 -pyrimidine derivatives as protein kinases inhibitors: W 0, 02096909 Al[P]. 2002 - 12 - 05 .
  • 9JIANGJK, GHORESCHI K, DEFLORIAN F, et al, Examining the chirality, conformation and selective kinase inhibition of 3- ( (3R ,4R) 4-methyl-3-( methyl ( 7 H-pyrrolo[2 ,3-dJ pyrimidin4- yl) amino) piperidin-l=yl ) -3-oxopropanenitrile ( CP-690, 550)[J].J Med Chern, 2008, 51(24) :8012 -8018.
  • 10HAO BY, LIUJQ, ZHANG WH, et al, A novel asymmetric syn?thesis of cis-f 3R, 4R ) -N-( tert-butoxycarbonyl ) 4-methyl-3- (methylamino) piperidine[J]. Synthesis, 2011, 2011 (8): 1208 -1212.

二级参考文献36

  • 1莫选荣,罗心静.类风湿性关节炎发病机制的研究进展[J].医学临床研究,2007,24(2):336-340. 被引量:45
  • 2US FDA. FDA approves Xeljanz for rheumatoid arthritis[ EB/ OL ]. [ 2012 -11 - 06 ]. http://www, fda. gov/NewsEvents/ N ucm327152, htm.
  • 3CAI W L, CONONY J L FROST H, et al. Investigation of practical routes for the kilogram-scale production of cis-3- methylamino-4-methylpiperidines[ J]. Org Process Res Dev, 2005,9(1) :51 -56.
  • 4RIBIN D H B. 3-Amino-piperidine derivatives and methods of manufacture: US,20040102627 [ P ]. 2004 - 05 - 27.
  • 5RUGGER/ S G, HAWKINS J M, MAKOWSKI T M, et al. Pyrrolo [ 2,3-d] pyrimidine derivatives: their intermediates and synthesis : US ,8309716 [ P]. 2012 - 11 - 13.
  • 6PRICE K E, LARRIVEE-ABOUSSAFY C, LILLIE B M, et al. Mild and efficient DBU-catalyzed amidation of cyanoace- tates[J]. Org Lett,2009,11 (9) :2003 -2006.
  • 7ARNETT FC,EDWORTHY SM, BLOCH DA,et al. The American rheumatism association 1987 revised criteria for classification ofrheumatoid arthritis [ J ]. Arthritis Rheum, 1988,31 ( 3 ) : 315 - 324.
  • 8PERICOLINI E, ALUNNO A, GABRIELLI E, et al. The microbial capsular polysaceharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients [J]. PLoS 0ne,2013,8(1): e53336.
  • 9ZERBINI CA, LOMONTE AB. Tofaeitinib for the treatment of rheumatoid arthritis [J]. Expert Rev Clin lmmunol, 2012,8 (4) : 319 -331.
  • 10CHAPARRO DEL MORAL R, RILLO OL,CASALLA L, et al. Work productivity in rheumatoid arthritis: relationship with clinical and radiological features[ J]. Arthritis, 2012 : 137635.

共引文献21

同被引文献18

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部